Australia
· Delayed Price · Currency is AUD Genetic Signatures Company Description
Genetic Signatures Limited operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas.
The company offers enteric bacteria, Enteroaggregative E.coli aggR and aaiC, enteric viral, enteric protozoan, enteric protozoan extended, enteric microsporidia, respiratory pathogen, SARS-CoV-2, SARS-CoV-2 respiratory plus, coronavirus, atypical respiratory, pertussis and PCP, parainfluenza 4, STI genital pathogen, extended spectrum beta-lactamase and carbapenemase producing organisms, viral meningitis, flavivirus dengue alphavirus, flavivirus reflex, dengue typing, and alphavirus reflex Detection kits under the EasyScreen name.
Genetic Signatures Limited was incorporated in 2001 and is headquartered in Newtown, Australia.
| Country | Australia |
| Founded | 2001 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| CEO | Allison Rossiter |
Contact Details
Address: Heart Research Institute Newtown, 2042 Australia | |
| Phone | 61 2 9870 7580 |
| Website | geneticsignatures.com |
Stock Details
| Ticker Symbol | GSS |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU000000GSS4 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Allison Rossiter | Chief Executive Officer |
| Karl David Pechmann | Chief Financial Officer, Chief Operating Officer and Company Secretary |
| Michael Anton Aicher BSc, M.B.A., MBA | Executive Director of US Operations and Executive Director |
| Christopher M. Abbott A.M., AM, F.C.A., FCA, Ph.D., Ph.D., (Hon) | Founder and Chairman Emeritus |
| Rebecca Abbatantuono | Global Head of People and Culture |
| Neralie Coulston B.Sc. | Global Head of Regulatory Affairs |
| Rohan Baker | Head of Research and Acting QC Manager |